THERMOCAP LABORATORIES INC.

Biotech · Private

DNA-based differential scanning calorimetry assay for mass quantification of biological compounds in unpurified samples

Grants
$1.7M
3 awards
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
4
1 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase I · DNA-based assay for calorimetric determination and quantitation of protein concentrations in pure or mixed solutions$258,625
Federal grantNational Science Foundation · Phase I · SBIR Phase I: High-Throughput Direct Ratiometric Calorimeter for Drug Discovery$275,000
Federal grantNational Science Foundation · Phase II · SBIR Phase II: High-Throughput Differential Scanning Calorimeter for Drug Discovery and Research$1,145,664
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2958TEZCAT Laboratories LLC——
2959Korsana Biosciences——
2960ONE-DERINGS LLC——
2961THERMOCAP LABORATORIES INC.——
2962SPIRO THERAPEUTICS LLC——
2963PAPIVAX, LLC——
2964Nutriforward, LLC——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 1 granted of 4
  • Concurrent Thermal Measurements Of A Plurality Of Samplesapplication
  • Concurrent Thermal Measurements Of A Plurality Of Samplesgranted
  • Concurrent Thermal Measurements Of A Plurality Of Samplesapplication
  • Concurrent Thermal Measurements Of A Plurality Of Samplesapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.